vs

Side-by-side financial comparison of Allegion (ALLE) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.0B, roughly 1.6× Allegion). Allegion runs the higher net margin — 13.4% vs -58.9%, a 72.2% gap on every dollar of revenue. On growth, Allegion posted the faster year-over-year revenue change (9.7% vs 6.2%). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 3.5%).

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facili...

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

ALLE vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.6× larger
IVZ
$1.7B
$1.0B
ALLE
Growing faster (revenue YoY)
ALLE
ALLE
+3.5% gap
ALLE
9.7%
6.2%
IVZ
Higher net margin
ALLE
ALLE
72.2% more per $
ALLE
13.4%
-58.9%
IVZ
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
3.5%
ALLE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALLE
ALLE
IVZ
IVZ
Revenue
$1.0B
$1.7B
Net Profit
$138.1M
$-995.9M
Gross Margin
44.0%
Operating Margin
18.9%
-86.2%
Net Margin
13.4%
-58.9%
Revenue YoY
9.7%
6.2%
Net Profit YoY
-6.8%
-575.8%
EPS (diluted)
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALLE
ALLE
IVZ
IVZ
Q1 26
$1.0B
Q4 25
$1.0B
$1.7B
Q3 25
$1.1B
$1.6B
Q2 25
$1.0B
$1.5B
Q1 25
$941.9M
$1.5B
Q4 24
$945.6M
$1.6B
Q3 24
$967.1M
$1.5B
Q2 24
$965.6M
$1.5B
Net Profit
ALLE
ALLE
IVZ
IVZ
Q1 26
$138.1M
Q4 25
$147.5M
$-995.9M
Q3 25
$188.4M
$356.4M
Q2 25
$159.7M
$197.4M
Q1 25
$148.2M
$171.1M
Q4 24
$144.1M
$209.3M
Q3 24
$174.2M
$55.0M
Q2 24
$155.4M
$132.2M
Gross Margin
ALLE
ALLE
IVZ
IVZ
Q1 26
44.0%
Q4 25
44.5%
Q3 25
45.8%
Q2 25
45.6%
Q1 25
44.9%
Q4 24
44.1%
Q3 24
44.7%
Q2 24
44.4%
Operating Margin
ALLE
ALLE
IVZ
IVZ
Q1 26
18.9%
Q4 25
20.3%
-86.2%
Q3 25
21.8%
16.5%
Q2 25
21.5%
14.1%
Q1 25
20.9%
18.1%
Q4 24
19.5%
19.6%
Q3 24
22.2%
6.6%
Q2 24
21.6%
13.9%
Net Margin
ALLE
ALLE
IVZ
IVZ
Q1 26
13.4%
Q4 25
14.3%
-58.9%
Q3 25
17.6%
21.7%
Q2 25
15.6%
13.0%
Q1 25
15.7%
11.2%
Q4 24
15.2%
13.1%
Q3 24
18.0%
3.6%
Q2 24
16.1%
8.9%
EPS (diluted)
ALLE
ALLE
IVZ
IVZ
Q1 26
Q4 25
$1.70
$-2.61
Q3 25
$2.18
$0.66
Q2 25
$1.85
$-0.03
Q1 25
$1.71
$0.38
Q4 24
$1.65
$0.46
Q3 24
$1.99
$0.12
Q2 24
$1.77
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALLE
ALLE
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$308.9M
$1.0B
Total DebtLower is stronger
$2.0B
$1.8B
Stockholders' EquityBook value
$2.1B
$12.2B
Total Assets
$5.3B
$27.1B
Debt / EquityLower = less leverage
0.97×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALLE
ALLE
IVZ
IVZ
Q1 26
$308.9M
Q4 25
$356.2M
$1.0B
Q3 25
$302.7M
$973.1M
Q2 25
$656.8M
$922.7M
Q1 25
$494.5M
$821.7M
Q4 24
$503.8M
$986.5M
Q3 24
$878.9M
$1.0B
Q2 24
$747.5M
$878.5M
Total Debt
ALLE
ALLE
IVZ
IVZ
Q1 26
$2.0B
Q4 25
$2.0B
$1.8B
Q3 25
$2.1B
$1.6B
Q2 25
$2.1B
$1.9B
Q1 25
$2.0B
$964.8M
Q4 24
$2.0B
$890.6M
Q3 24
$2.4B
$890.3M
Q2 24
$2.4B
$890.1M
Stockholders' Equity
ALLE
ALLE
IVZ
IVZ
Q1 26
$2.1B
Q4 25
$2.1B
$12.2B
Q3 25
$1.9B
$14.0B
Q2 25
$1.8B
$13.9B
Q1 25
$1.6B
$14.7B
Q4 24
$1.5B
$14.6B
Q3 24
$1.6B
$14.8B
Q2 24
$1.4B
$14.6B
Total Assets
ALLE
ALLE
IVZ
IVZ
Q1 26
$5.3B
Q4 25
$5.2B
$27.1B
Q3 25
$5.2B
$28.4B
Q2 25
$4.9B
$28.5B
Q1 25
$4.6B
$28.1B
Q4 24
$4.5B
$27.0B
Q3 24
$5.0B
$27.5B
Q2 24
$4.8B
$27.2B
Debt / Equity
ALLE
ALLE
IVZ
IVZ
Q1 26
0.97×
Q4 25
0.96×
0.15×
Q3 25
1.07×
0.12×
Q2 25
1.16×
0.14×
Q1 25
1.24×
0.07×
Q4 24
1.33×
0.06×
Q3 24
1.53×
0.06×
Q2 24
1.69×
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALLE
ALLE
IVZ
IVZ
Operating Cash FlowLast quarter
$101.3M
$455.8M
Free Cash FlowOCF − Capex
$432.2M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
2.0%
1.4%
Cash ConversionOCF / Net Profit
0.73×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALLE
ALLE
IVZ
IVZ
Q1 26
$101.3M
Q4 25
$240.1M
$455.8M
Q3 25
$229.5M
$606.2M
Q2 25
$209.7M
$547.9M
Q1 25
$104.5M
$-84.6M
Q4 24
$219.0M
$316.9M
Q3 24
$231.9M
$438.4M
Q2 24
$173.0M
$489.1M
Free Cash Flow
ALLE
ALLE
IVZ
IVZ
Q1 26
Q4 25
$200.5M
$432.2M
Q3 25
$209.8M
$586.4M
Q2 25
$192.0M
$530.4M
Q1 25
$83.4M
$-108.0M
Q4 24
$194.9M
$309.9M
Q3 24
$212.0M
$410.0M
Q2 24
$152.1M
$462.4M
FCF Margin
ALLE
ALLE
IVZ
IVZ
Q1 26
Q4 25
19.4%
25.5%
Q3 25
19.6%
35.7%
Q2 25
18.8%
35.0%
Q1 25
8.9%
-7.1%
Q4 24
20.6%
19.5%
Q3 24
21.9%
27.1%
Q2 24
15.8%
31.2%
Capex Intensity
ALLE
ALLE
IVZ
IVZ
Q1 26
2.0%
Q4 25
3.8%
1.4%
Q3 25
1.8%
1.2%
Q2 25
1.7%
1.2%
Q1 25
2.2%
1.5%
Q4 24
2.5%
0.4%
Q3 24
2.1%
1.9%
Q2 24
2.2%
1.8%
Cash Conversion
ALLE
ALLE
IVZ
IVZ
Q1 26
0.73×
Q4 25
1.63×
Q3 25
1.22×
1.70×
Q2 25
1.31×
2.78×
Q1 25
0.71×
-0.49×
Q4 24
1.52×
1.51×
Q3 24
1.33×
7.97×
Q2 24
1.11×
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALLE
ALLE

Allegion Americas$809.9M78%
Allegion International$223.7M22%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons